Recro Pharma to Report First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9, 2018
May 02, 2018 07:00 ET
|
Recro Pharma, Inc.
Conference Call and Webcast Scheduled for Wednesday, May 9, 2018 at 8:00 a.m. ET MALVERN, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty...
Recro Pharma Presents Data for Neuromuscular Blocking and Reversal Agents at the AUA 2018 Annual Meeting
April 30, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., April 30, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma to Present IV Meloxicam Data at the 43rd Annual Regional Anesthesiology and Acute Pain Medicine Meeting
April 16, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., April 16, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma Announces Commercial Team Additions
March 29, 2018 16:05 ET
|
Recro Pharma, Inc.
MALVERN, Pa., March 29, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute...
Recro Pharma Announces Publication of Phase III IV Meloxicam Bunionectomy Data in the Clinical Journal of Pain
March 27, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., March 27, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma to Present at the 17th Annual Needham Healthcare Conference
March 21, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma to Present at Upcoming Investor Conferences
March 06, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma Announces an Educational Symposium on Challenges in Acute Pain Management and Advances in Evidence-Based Management Approaches at the American Academy of Orthopaedic Surgeons 2018 Annual Meeting
March 05, 2018 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
Recro Pharma Announces Commercial Team Additions
March 02, 2018 16:05 ET
|
Recro Pharma, Inc.
MALVERN, Pa., March 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care...
Recro Pharma Reports Year End 2017 Financial Results
February 27, 2018 07:00 ET
|
Recro Pharma, Inc.
IV Meloxicam NDA Submitted and PDUFA Action Date Set for May 26, 2018 Record CDMO Performance; 2017 Revenues of $71.8 Million MALVERN, Pa., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc....